NCEPATPNational Cholesterol Education Program Adult Treatment Panel
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
The agreement between IDF with WHO and NCEP-ATP III criteria was 0.37 (p < 0.001) and 0.53 (p < 0.001), respectively, whereas the agreement between NCEPATP III and WHO criteria was 0.24 (p < 0.001).
Modification of the NCEPATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease.
For the individuals in TARA, the definition of metabolic syndrome developed by the National Cholesterol Education Program Adult Treatment Panel III (NCEPATP III) results in a prevalence of 11%, a sensitivity of 21%, and a specificity of 97%.
The reported prevalence of MetS based on NCEPATP definition was within the range 3.75-25.6%.
The prevalence of MetS among Ghanaians was estimated to be in the range 6-21.2% based on three guidelines, NCEPATP, WHO, and IDF.
The overall prevalence of metabolic syndrome among the study population was 63.58%, 43.83%, and 69.14% using the World Health Organization (WHO), the National Cholesterol Education Program, Adult Treatment Panel III (NCEPATP III), and the International Diabetes Federation (IDF) criteria, respectively.